Oxylipins in Breast Implant-Associated Systemic Symptoms

Area of Science:

• Biochemistry
• Immunology
• Plastic Surgery

Background:

• Systemic symptoms associated with breast implants (SSBI) are nonspecific and mimic autoimmune disorders.
• Breast implants can create an oxidative environment, leading to lipid oxidation and the formation of immunogenic oxylipins.
• Oxylipins play a role in immune responses and inflammation.

Purpose of the Study:

• To investigate the abundance of various oxylipins in periprosthetic breast tissue.
• To determine if oxylipins are associated with SSBI in patients.
• To explore the relationship between oxylipin levels and common SSBI manifestations.

Main Methods:

• Analysis of 120 patients across three cohorts: SSBI, non-SSBI controls, and no-implant controls.
• Lipid extraction and oxylipin quantification using liquid chromatography-mass spectrometry (LC-MS/MS).
• Targeted analysis of breast adipose tissue.

Main Results:

• Five out of 15 analyzed oxylipins showed increased abundance in the SSBI cohort compared to control groups.
• The study identified specific oxylipins associated with SSBI patients.

Conclusions:

• Documents a clear association between specific oxylipins and patient-reported manifestations of SSBI.
• Provides objective data to support subjective symptom reporting in SSBI patients.
• Highlights potentially relevant symptoms linked to oxylipin abundance.